Miami Biotech Collective Summit Powered by J.P. Morgan

​Miami Biotech Collective Summit powered by J.P. Morgan
The Art of Driving the Future of Biotech in South Florida

​We’re proud to introduce the inaugural Miami Biotech Collective Summit powered by J.P. Morgan — a first-of-its-kind gathering designed to convene ~80 biotech CEOs, investors, and ecosystem leaders to explore what it takes to build and finance the next generation of biotech companies in South Florida.

​With J.P. Morgan’s data-driven support, the Summit is designed to elevate South Florida’s biotech community by grounding strategic discussions in market intelligence and forward-looking insights as we close out 2025 and look ahead to 2026. Together, we’ll examine the capital, talent, and infrastructure shaping the region’s emergence as a biotech hub.

​The afternoon will feature two main segments:

• ​The Art of Financing the Next Wave

• ​The Art of Building Biotech

​A networking reception will follow immediately after the program.

​Space is limited. Please RSVP by November 5th so we can extend invitations to other guests.

​+++

​Confirmed Participants

​Investors & Bankers
Carl Gordon – Managing Partner, OrbiMed
Shawn Titcomb – CEO, Allele Capital Partners
Adam Rogers – Partner, PFP Biosciences
Daniel Krizek – Portfolio Manager, Surveyor Capital
Claudine Prowse – Venture Partner, J.P. Morgan
Mike Yee – Managing Director, Industry Analyst

​Biotech Executives
Brent Saunders – Chairman & CEO, Bausch + Lomb
Fred Hassan – Chairman, Caret Group
David Epstein – Chairman & CEO, Ottimo Pharma
David Moss – CEO & Co-Founder, INmune Bio
Daniel Teper – CEO, Naya Therapeutics
Scott Braunstein – Independent Director
Neil McFarlane – CEO, Zevra Therapeutics
Rich Daly – President & CEO, Catalyst Pharmaceuticals

​Academic & Health System Leaders
Stephen Nimer – Sylvester Comprehensive Cancer Center
Duane Mitchell – UF CTSI
Jackson Streeter – UF Innovate Ventures & DeepWork

​

​Program Agenda

​Welcome & Opening Remarks
Raquel Cabo | Founder, Miami Biotech Collective

​Part 1 | The Art of Financing the Next Wave
Early Financing Strategies
Building Market-Ready Companies

​Break

​Part 2 | The Art of Building Biotech
Building for Scale: From Vision to Critical Mass
Closing Keynote: Lessons from Transformative Deals and Partnerships

​Reception
5:00-7:00 PM